Medications like Ozempic, Mounjaro, and Wegovy are transforming how nursing homes manage diabetes and obesity. If your parent was recently started on one of these drugs — known as GLP-1 receptor agonists — during a rehab stay or while in long-term care, you're probably hearing a lot of good news about blood sugar control and weight loss.
But here's what most families aren't told: these medications work differently in a frail 80-year-old than they do in a healthy 50-year-old. The same drug that helps someone lose weight and reduce their heart disease risk can quietly create new problems in a nursing home resident — problems like dangerous dehydration, rapid muscle loss, and nutritional gaps that accelerate decline.
The good news is that the right facility, with the right protocols, can manage these risks well. The key is knowing what to ask.
Here are five questions every family caregiver should be asking right now.
1. "Has the kitchen adjusted my parent's meals — or are they still getting a standard tray?"
This is the question most families never think to ask, and it matters more than almost anything else on this list.
GLP-1 medications work partly by slowing down how fast the stomach empties. That means your parent feels full faster, stays full longer, and may feel nauseous when faced with a large plate of food. Roughly 44% of people taking semaglutide experience nausea, and about a quarter deal with vomiting or constipation.
In a nursing home that hasn't adapted, this plays out in a predictable way: your parent gets served the same cafeteria-style tray as everyone else, eats a few bites, pushes it away, and the plate goes back to the kitchen mostly untouched. Over weeks and months, they're quietly becoming malnourished — not because the facility isn't serving food, but because the food isn't designed for someone on these medications.
What a good answer sounds like: "We've moved your mother to five or six smaller meals throughout the day. Our dietitian reviewed her plan and we're prioritizing protein at every meal — her target is between 1.0 and 1.5 grams of protein per kilogram of body weight."
What a red flag sounds like: "She gets the same menu as everyone else. We can offer a snack if she asks for one."
If the facility doesn't have a registered dietitian actively managing your parent's nutrition while they're on a GLP-1, that's a significant gap in care.
2. "What is the facility doing to make sure my parent stays hydrated?"
This is the sleeper risk that families almost never hear about. GLP-1 medications can reduce the sensation of thirst. Your parent may not feel thirsty even when their body is running low on fluids. In a nursing home setting, where residents may already struggle to drink enough water on their own, this creates a dangerous combination.
Dehydration in an elderly person doesn't always look like what you'd expect. It can show up as sudden confusion, dizziness when standing, or a urinary tract infection that seems to come out of nowhere. In serious cases, it can trigger acute kidney injury — a medical emergency that sends residents to the hospital.
What a good answer sounds like: "We do scheduled hydration rounds throughout the day. We also track her fluid intake at every meal and snack, and we've added high-water-content options like soups, yogurts, and fruit between meals. The nurses check orthostatic vitals regularly."
What a red flag sounds like: "There's always water on her nightstand."
Water on the nightstand isn't a hydration plan. It's furniture. A facility managing GLP-1 therapy well has a proactive system for getting fluids into residents who may not ask for them.
3. "Is my parent getting physical therapy to protect their muscle mass?"
When most people hear that their parent is losing weight in a nursing home, the instinct is to feel relieved. But weight loss on a GLP-1 drug isn't just fat loss — it's also muscle loss. And in a frail older adult, muscle is everything.
The medical term is sarcopenia — the age-related loss of muscle mass, strength, and function. It's already one of the most common conditions in nursing homes, and it's a leading predictor of falls, fractures, and loss of independence. When a GLP-1 medication accelerates weight loss, it can accelerate muscle loss right along with it, especially if no one is actively working to prevent that.
The 2025 standards from the American Diabetes Association are clear: patients on GLP-1 weight-loss therapy should be doing muscle-strengthening exercises. In a nursing home, that means physical therapy — not just walking the hallway, but guided resistance training designed to preserve the muscle your parent needs to get out of a chair, keep their balance, and avoid a fall.
What a good answer sounds like: "Your father is enrolled in a resistance training program with our physical therapy team. We're tracking his grip strength and gait speed monthly, and we adjust the program as his weight changes."
What a red flag sounds like: "He walks to the dining room. That's his exercise."
Walking to the dining room is mobility. It's not a muscle preservation strategy. If your parent is losing weight on one of these medications and isn't getting structured PT, ask why — and keep asking.
4. "Does the nursing staff know to hold this medication before procedures?"
This question could save your parent's life, and it's one that falls through the cracks more often than it should.
Because GLP-1 drugs slow gastric emptying, food can stay in the stomach much longer than normal. If your parent needs any kind of procedure that involves anesthesia or sedation — even something routine like a colonoscopy or a dental procedure — there's a real risk that food still sitting in the stomach could be aspirated into the lungs. Pulmonary aspiration is a serious, potentially fatal complication.
Current clinical guidelines recommend holding weekly injectable GLP-1 medications for seven days before a scheduled procedure. For daily oral versions like Rybelsus, the medication should be held on the day of the procedure. In some cases — especially if your parent is in the early dose-escalation phase or has been having significant GI side effects — a 24-hour clear-liquid diet before surgery may also be necessary.
The risk is highest during care transitions. When your parent is transferred from the nursing home to a hospital or surgical center, medication details can get lost in the handoff. Make sure the facility has a clear protocol for communicating GLP-1 status to the surgical team.
What a good answer sounds like: "Anytime a procedure is scheduled, our nurses flag GLP-1 medications on the transfer paperwork and follow our holding protocol. We also coordinate with the surgical team directly."
What a red flag sounds like: "The hospital handles all of that."
The hospital handles a lot of things. But medication reconciliation errors during transitions of care are one of the most common sources of preventable harm in healthcare. This is a conversation your parent's nursing home should be leading, not leaving to chance.
5. "Has anyone talked to my parent about what this medication is doing to their body?"
This is the question that gets at something deeper than clinical protocols. It's about dignity.
GLP-1 medications can make food taste different, reduce the pleasure of eating, and cause uncomfortable side effects like nausea and bloating. For a nursing home resident — someone whose daily pleasures may already be limited — losing the enjoyment of meals is not a small thing.
Resident-centered care means your parent understands what the medication is doing, why their appetite has changed, and what the trade-offs are. It means their personal food preferences are being honored as much as possible, even within the constraints of a modified nutrition plan. It means someone has talked to them — not just about them — about the goals of this therapy and whether they want to continue it.
Federal and state regulators are paying closer attention to this. Facilities are expected to document that residents have been informed about the risks of therapies that cause weight loss, and that nutritional care plans reflect individual preferences. A facility that can't show you evidence of that conversation is a facility that isn't meeting the standard.
What a good answer sounds like: "We had a care conference with your mother last month to go over how she's feeling on the medication. She told us she misses having a full breakfast, so our dietitian worked with her to find a high-protein breakfast option she actually enjoys. It's documented in her care plan."
What a red flag sounds like: "The doctor prescribed it."
A prescription isn't a plan. Your parent deserves both.
What to Do With These Answers
If you asked all five questions and got solid answers, your parent is probably in a facility that takes this seriously. That's worth recognizing — good metabolic care in a nursing home takes real coordination between nurses, dietitians, therapists, and aides.
If the answers were vague, defensive, or confused, that doesn't necessarily mean your parent is in danger today. But it does mean the facility hasn't caught up with the clinical reality of these medications. And that gap between what's prescribed and what's actually managed on the floor is where preventable harm happens.
Use what you've learned to start a conversation with the director of nursing or the medical director. Bring specific requests. Ask for a care plan meeting. Document what you're told.
And if you're evaluating nursing homes — for your parent now or for a future decision — look for facilities that can speak to these issues clearly. The ones that can are the ones investing in the kind of clinical infrastructure that matters most when your family member's health is on the line.
GLP-1 medications like Ozempic, Mounjaro, and Wegovy are changing how nursing homes manage chronic disease — but not every facility is keeping pace. NursingHomeIQ helps families evaluate nursing homes using real data, so you can find the care your loved one deserves.